Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04826224Phase 1Terminated
Phase 1, open-label, single-arm trial of autologous bone marrow cell concentrate in shoulder osteoarthritis. Primary endpoints: Adverse Reactions and Morbidity related to bone marrow aspirations from iliac crests. Started Dec 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04826224.